Politicians—from mayors and senators to the nation’s FDA Commissioner and President—are focused on the magnitude of the current U.S. opioid epidemic. Driven by the past ease of obtaining opioids, these medications have emerged as the gateway to a lifetime of drug addiction. As a result, communities across the U.S. are contending with the personal, financial and societal costs of their misuse.

In response to this problem, Curadite has developed a scalable opioid management platform that combines cellular-enabled packaging with usage re- minders/messages, education, and incentives. Everyone wins with Curadite

• patients receive long-term access to vital pain management medications
• families have access to resources necessary to support their loved ones
• healthcare systems receive the tools they need to monitor use patterns
• society benefits from the return of unused, controlled medications

 

Over 115 Americans die every day from opioid overdose. With the design of custom packaging, Curadite provides increased access to Narcan, the lifesaving, non-addictive drug that reverses opioid overdose. According to Sarah Wakeman, MD, medical director of the Substance Use Disorder Initiative and the Addiction Consult Team at Boston’s Massachusetts General Hospital, “Co-prescribing naloxone is important to ensure all people being prescribed opioids at risk for overdose have this lifesaving medication at home, similar to how we might think about co-prescribing glucagon to someone with insulin-dependent diabetes.”